Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Sen. Tom Harkin (D-Iowa) announces plans to seek more research funding for NIH's Office of Dietary Supplements. Speaking at the CHPA's dietary supplement symposium in Arlington, Va. Sept. 14, Harkin says ODS in September will award a grant establishing its first university-based botanical research center. Funding will come from a $2 mil. FY 1999 appropriation for the initiative, and ODS plans to create a total of eight research centers during the next few years (1"The Tan Sheet" May 10, p. 12). ODS Acting Director Rebecca Costello, PhD, reports there has been "discussion" about moving ODS into the NIH National Center for Complementary & Alternative Medicine

You may also be interested in...

NIH Request For Specialized Botanicals Research Center Applications Issued

The National Institutes of Health Office of Dietary Supplements has issued a request for applications (RFA OD-99-007) to establish "specialized research centers to investigate the biological effects of botanicals including, but not limited to, botanicals available as dietary supplements."

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts